Share chart Cipla Limited
About Cipla Limited
Cipla Limited вместе со своими дочерними компаниями производит и продает фармацевтическую продукцию в Индии, США, Южной Африке и за рубежом. Компания предлагает активные фармацевтические ингредиенты; и составы в различных терапевтических областях, таких как ИМ, стенокардия, сердечная недостаточность, гипертония, аритмия, нарушения липидов и диабет, ожирение, ВИЧ, респираторные заболевания, урология, онкология, кардиометаболизм, здоровье детей, инфекционные заболевания и реанимация, гепатит, женское здоровье, офтальмология и нейропсихиатрия. more details| ISIN | INE059A01026 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | inr |
| Валюта отчета | inr |
| Див.доход ао | 1.39 |
| Дивиденд ао | 13 |
| Сайт | https://www.cipla.com |
| Цена ао | 1520.1 |
| Change price per day: | -1.55% (1520.1) |
|---|---|
| Change price per week: | -0.9596% (1511) |
| Change price per month: | +2.29% (1463.05) |
| Change price per 3 month: | +3.11% (1451.4) |
| Change price per half year: | -0.3197% (1501.3) |
| Change price per year: | +6.47% (1405.5) |
| Change price per 3 year: | +53.97% (971.95) |
| Change price per 5 year: | +154.57% (587.85) |
| Change price per year to date: | +1.42% (1475.5) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 7209048 | 0.89 |
| Vanguard International Stock Index-Total Intl Stock Indx | 6629962 | 0.82 |
| Advisors Inner Circle Fund III-GQG Partners Emerging Markets Equity Fd | 5032866 | 0.62 |
| iShares Core MSCI Emerging Markets ETF | 4328274 | 0.54 |
| Hartford/Schroders Emerging Markets Equity Fd | 3016357 | 0.37 |
| iShares MSCI Emerging Markets ETF | 1961337 | 0.24 |
| DFA Emerging Markets Core Equity Portfolio | 1598801 | 0.2 |
| Fidelity SAI Emerging Markets Low Volatility Index Fund | 1430891 | 0.18 |
| Mercer Emerging Markets Equity Fd | 1178896 | 0.15 |
| Driehaus Emerging Markets Growth Fund | 1127122 | 0.14 |
| Fidelity SAI Emerging Markets Value Index Fund | 1063438 | 0.13 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 969506 | 0.12 |
| DFA Investment Dimensions-DFA Emerging Mkts Value | 896605 | 0.11 |
| DFA Emerging Markets Series | 657406 | 0.08 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF | 0.23206 | 17.59 | 2.86877 |
| 0.23 | 17.59 | 2.87 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Raju Sunil Mistry M.A., Ph.D. | President & Global Chief People Officer | N/A | 1965 (60 years) |
| Mr. Pradeep Bhadauria | President & Global Chief Scientific Officer | N/A | |
| Mr. Ashish Adukia | Global Chief Financial Officer | N/A | |
| Mr. Dinesh Ramniranjan Jain | Senior VP & Head of Corporate Finance | N/A | |
| Mr. Naveen Bansal | Head of Investor Relations | N/A | |
| Mr. Rajendra Kumar Chopra | Compliance Officer & Company Secretary | 15.3M | |
| Ms. Heena Kanal | Senior Vice-President of Corporate Communications | N/A | |
| Mr. Umang Vohra B.E., M.B.A. | MD, Global CEO & Executive Director | 1971 (54 years) | |
| Ms. Sneha Hiranandani B Com | Chief Information Officer | ||
| Dr. Jaideep A. Gogtay M.D., Ph.D. | Global Chief Medical Officer | 1967 (58 years) |
Address: India, Mumbai, Cipla House - open in Google maps, open in Yandex maps
Website: https://www.cipla.com
Website: https://www.cipla.com
